Bioreactors and Fermenters Market Report 2025

This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The bioreactors and fermenters market size has grown rapidly in recent years. It will grow from $4.12 billion in 2024 to $4.72 billion in 2025 at a compound annual growth rate (CAGR) of 14.7%. The growth in the historic period can be attributed to increasing demand for biopharmaceuticals, growing investments in research and development activities, expansion of the biotechnology industry, increasing focus on sustainable practices, and demand for personalized medicine.

The bioreactors and fermenters market size is expected to see rapid growth in the next few years. It will grow to $8.08 billion in 2029 at a compound annual growth rate (CAGR) of 14.4%. The growth in the forecast period can be attributed to emerging biopharmaceutical companies, demand for vaccine production, focus on precision medicine, expansion of biotechnology research, rising investments in healthcare infrastructure. Major trends in the forecast period include increased adoption of next generation bioreactor technologies, expansion of bioproduction capacities in emerging markets, rise of integrated continuous bioprocessing, growing focus on sustainability and green bioprocessing, integration of artificial intelligence and machine learning.

The growth of the bioreactors and fermenters market is expected to be driven by increasing investments in biotechnology. Biotechnology investment refers to the allocation of financial resources, such as capital or funding, into companies, projects, or ventures within the biotechnology sector. This surge in investment is driven by the rising demand for innovative healthcare solutions and advancements in genetic engineering. Biotechnology funding plays a crucial role in advancing biotechnological processes and accelerating biopharmaceutical production by supporting R&D efforts to improve bioreactor and fermenter technologies. Additionally, it aids in scaling up and commercializing these technologies, facilitating their adoption in industrial biomanufacturing settings. For example, in August 2024, the UK Biotech Financing Report published by the BioIndustry Association (BIA) revealed that the UK biotech sector experienced significant financial growth, with $2.49 billion (£1.98 billion) raised in Q1 and Q2 2024 - surpassing the total raised in 2023, which was $2.25 billion (£1.8 billion). As a result, the rise in biotechnology investments is driving the expansion of the bioreactors and fermenters market.

Leading companies in the bioreactors and fermenters market are leveraging innovation to enhance profitability by developing advanced technological solutions. Next-Gen bioreactor remote monitoring and control software represent one such innovation, providing specialized computer programs or systems designed to oversee and manage bioreactors and fermenters remotely. For example, The Cultivated B GmbH introduced AUXO V software in November 2023, offering real-time monitoring and personalized interfaces accessible remotely via phone and web-based platforms. This next-generation software enables direct or remote control of bioprocesses, ensuring 24/7 monitoring for prompt intervention and automated processes to optimize workforce allocation.

In August 2024, Zydus Lifesciences Limited, a pharmaceutical company based in India, acquired a 50% stake in Sterling Biotech Ltd. for an undisclosed sum. This joint venture aims to establish a state-of-the-art facility for producing fermented animal-free protein, targeting global markets. Sterling Biotech Ltd., an India-based biotechnology company, specializes in the development of innovative fermentation technologies.

Major companies operating in the bioreactors and fermenters market are Merck & Co. Inc., Thermo Fisher Scientific Inc., Danaher Corporation, GE Healthcare, Sartorius AG, Getinge AB, Eppendorf AG, ZETA Holding, Pierre Guerin SAS, Parr Instrument Company, Bionet Inc., PBS Biotech, Bioengineering AG, Finesse Solutions, Ollital Technology, Shanghai Bailun Biological Technology, Zhengzhou Laboao Instrument Equipment, Scigenics Pvt. Ltd., Infors AG, Synthecon Inc., Cellexus Ltd.

North America was the largest region in the bioreactors and fermenters market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the bioreactors and fermenters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the bioreactors and fermenters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bioreactors and fermenters market consists of sales of stirred-tank bioreactors, batch bioreactors, stirred-tank bioreactors, photobioreactors, and anaerobic fermenters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

Bioreactors and fermenters are specialized systems crucial in biotechnology and industrial operations, facilitating the controlled cultivation and growth of microorganisms, cells, or tissues. They provide a precisely regulated environment vital for the development and refinement of bioprocesses aimed at producing bio-based products. A bioreactor serves as a vessel tailored for the cultivation of microorganisms or cells under controlled conditions for various biotechnological applications. On the other hand, a fermentor is a subtype of bioreactor specifically engineered for microbial fermentation processes, primarily utilized in the production of enzymes, antibiotics, and biofuels.

The primary types of bioreactors and fermenters are single-use and multiple-use variants. Single-use bioreactors, also referred to as disposable bioreactors or reactors, are utilized in the biotechnology and pharmaceutical sectors for cultivating cells or microorganisms. Employing processes such as fed-batch, continuous, and batch operations, these bioreactors find application across a spectrum of end users including biopharmaceutical firms, beverage manufacturers, contract research organizations (CROs), as well as academic and research institutions.

The bioreactors and fermenters market research report is one of a series of new reports that provides bioreactors and fermenters market statistics, including bioreactors and fermenters industry global market size, regional shares, competitors with a bioreactors and fermenters market share, detailed bioreactors and fermenters market segments, market trends and opportunities, and any further data you may need to thrive in the bioreactors and fermenters industry. This bioreactors and fermenters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.